OPEN-SOURCE SCRIPT
PER x Range
This Pine Script calculates the target price of the Nikkei Average based on the EPS (Earnings Per Share) and different PER (Price-to-Earnings Ratio) multiples ranging from 17.5x to 12x, in increments of 0.5x. It then plots these target prices on the chart.
Key Features:
Input EPS: You can manually input the current EPS value of the Nikkei Average (the example uses 2380, but you can replace it with the actual EPS).
PER Multiples Calculation: The script calculates target prices for different PER multiples (17.5x, 17x, 16.5x, ..., down to 12x).
Plotting Target Prices: The calculated target prices (EPS * PER) are plotted on the chart as blue lines, showing you different target price scenarios based on varying PER multiples.
Key Features:
Input EPS: You can manually input the current EPS value of the Nikkei Average (the example uses 2380, but you can replace it with the actual EPS).
PER Multiples Calculation: The script calculates target prices for different PER multiples (17.5x, 17x, 16.5x, ..., down to 12x).
Plotting Target Prices: The calculated target prices (EPS * PER) are plotted on the chart as blue lines, showing you different target price scenarios based on varying PER multiples.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.